Strontium-89 Chloride in the Treatment of Bone Metastases from Breast Cancer

Publisher： Karger

E-ISSN： 1423-0232|55|5|377-381

ISSN： 0030-2414

Source： Oncology, Vol.55, Iss.5, 1998-08, pp. : 377-381

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment options for breast cancer and bone metastases

By Pecherstorfer Martin  

Women's Health, Vol. 5, Iss. 2, 2009-03 ,pp. : 149-163

Future Medicine

Access to resources Recommend Favorite

Serum Hemoglobin Levels Predict Response to Strontium-89 and Rhenium-186-HEDP Radionuclide Treatment for Painful Osseous Metastases in Prostate Cancer

By  

Urologia Internationalis, Vol. 77, Iss. 1, 2009-05 ,pp. : 50-56

Karger

Access to resources Recommend Favorite

Phase II Study of Loading-Dose Ibandronate Treatment in Patients with Breast Cancer and Bone Metastases Suffering from Moderate to Severe Pain

By  

Oncology Research and Treatment, Vol. 35, Iss. 5, 2012-04 ,pp. : 254-258

Karger

Access to resources Recommend Favorite

Treatment dynamics of bone‐targeting agents among men with bone metastases from prostate cancer in the United States

By  

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, Vol. 27, Iss. 2, 2018-02 ,pp. : 229-238

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Role of CXCR4 in the Prediction of Bone Metastases from Breast Cancer: A Pilot Study

By  

Oncology, Vol. 80, Iss. 3-4, 2011-07 ,pp. : 225-231

Karger

Access to resources Recommend Favorite